Brian William Tempest
About Brian William Tempest
Data last updated:
Brian William Tempest is a Director at R.L.Fine Chem Private Limited (since 2024). The companies operate in Pharma, Financial Services and Packaging. R.L.Fine Chem Private Limited reported revenue of ₹360 Cr (FY 2025). Earlier, Brian William Tempest was a Director at Religare Capital Markets Limited (2012–2018) and Director at Glenmark Pharmaceuticals Limited (2012–2024) and 4 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 R.L.Fine Chem Private Limited U24100KA2011PTC059846 | Director | 09 May 2024 | 2011 | ₹360 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Religare Capital Markets Limited U51909DL2007PLC159042 | Director | 27 Mar 2012 | 2007 | ₹135 Cr (FY 2016) | Active |
 Glenmark Pharmaceuticals Limited L24299MH1977PLC019982 | Director | 30 Jan 2012 | 1977 | ₹17,443 Cr (FY 2026) | Active |
 Innopac Abpackaging Private Limited U36100DL2015PTC275805 | Director | 03 Feb 2015 | 2015 | ₹112 Cr (FY 2025) | Active |
 Ranbaxy Laboratories Ltd L24231PB1961PLC003747 | Director | 09 Jul 2001 | 1961 | ₹1.3 Lakh (FY 2014) | Amalgamated |
 Fortis Healthcare Limited L85110PB1996PLC045933 | Director | 02 Aug 2011 | 1996 | ₹7,850 Cr (FY 2025) | Active |
 Agilus Diagnostics Limited U74899PB1995PLC045956 | Director | 04 Feb 2011 | 1995 | ₹1,432 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Brian William Tempest
| Name | DIN | Company | Designation |
|---|---|---|---|
| Anil Jain | 00181960 | R.L.Fine Chem Private Limited | Director |
| Rajesh Umakant Naik | 08327210 | R.L.Fine Chem Private Limited | Whole-Time Director |
| Sharat Pandu Rang Narasapur | 02808651 | R.L.Fine Chem Private Limited | Ceo |
| Sharat Pandurang Narasapur | R.L.Fine Chem Private Limited | Ceo |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Brian William Tempest
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Brian William Tempest
Brian William Tempest currently holds 1 directorship: R.L.Fine Chem Private Limited (Director, since 09 May 2024, revenue ₹360 Cr (FY 2025)).
Brian William Tempest was first appointed on 09 Jul 2001 as Director at Ranbaxy Laboratories Ltd. The most recent appointment on record is 09 May 2024 at R.L.Fine Chem Private Limited.
Brian William Tempest held 6 earlier board appointments: Religare Capital Markets Limited (Director, 27 Mar 2012 to 22 Apr 2018); Glenmark Pharmaceuticals Limited (Director, 30 Jan 2012 to 31 Mar 2024); Innopac Abpackaging Private Limited (Director, 03 Feb 2015 to 15 Jan 2020); Ranbaxy Laboratories Ltd (Director, 09 Jul 2001 to 19 Dec 2008); Fortis Healthcare Limited (Director, 02 Aug 2011 to 22 May 2018); and 1 more.
The current boards of Brian William Tempest's companies include Anil Jain (R.L.Fine Chem Private Limited), Rajesh Umakant Naik (R.L.Fine Chem Private Limited), Sharat Pandu Rang Narasapur (R.L.Fine Chem Private Limited), Sharat Pandurang Narasapur (R.L.Fine Chem Private Limited).